News
Perioral dermatitis is a skin condition characterized by a rash around the mouth. It is one type of dermatitis, which is a general term for skin irritation. In the word “perioral,” “peri ...
US-based pharmaceutical giant Eli Lilly has launched its diabetes and weight-loss drug, Mounjaro, in India, following approval from the Central Drugs Standard Control Organisation (CDSCO).
Pharma giant Eli Lilly has launched Mounjaro, a popular weight-loss drug, in India. Priced at Rs 3,500 for 2.5 mg and Rs 4,375 for 5 mg, Mounjaro is available by prescription and aims to address ...
ELi Lilly Weight Loss Drug: Popular anti-diabetes and obesity drug Mounjaro has been launched in India in a single-dose vial. While it has already been in strong demand in the US and Europe, the India ...
The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the pharmaceutical giant Eli Lilly on Thursday announcing the launch of tirzepatide ...
Eli Lilly and Company launched its weight loss drug Mounjaro in India on Thursday after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO). This is a drug which ...
Eli Lilly launched Mounjaro, a weight-loss injectable, in India, priced at ₹4,375 for 5 mg, targeting obesity and type-2 diabetes management. American drugmaker Eli Lilly and Company launched ...
Weight loss drugs such as Mounjaro help the body manage blood sugar more effectively, make one feel less hungry, and slow digestion, so the person feels full longer. Mounjaro, chemically known as ...
US pharma giant Eli Lilly's obesity management drug Mounjaro has now been launched in India. Interestingly, compared to the US, the price of Mounjaro in India will be one-fifth. Apart from obesity, ...
In a single-dose vial presentation Eli Lilly, a pharmaceutical firm has announced the launch of Mounjaro, following the authorization from the Central Drugs Standard Control Organization (CDSCO). The ...
India’s wait is over. The popular anti-obesity drug Mounjaro is finally here. The development comes after Eli Lilly received approval from India’s Central Drugs Standard Control Organisation (CDSCO).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results